Pictured: Peter Allen
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, June 18, 2014

A new drug could make pancreatic surgery safer by reducing the risk of a grave complication.

Pictured: Larry Norton
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, June 10, 2014

Memorial Sloan Kettering experts say that new information about the biology of breast cancer is revolutionizing the way they look at the disease.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: Jamie Ostroff
On Our Website
By Andrea Peirce, BA, Writer/Editor  |  Friday, May 30, 2014

Become one of the thousands of people that Memorial Sloan Kettering’s Tobacco Treatment Program has helped to quit.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: Tari King
In the News
By Jennifer Bassett, MA, Writer/Editor  |  Thursday, May 22, 2014

Memorial Sloan Kettering breast surgeon Tari King talks to CBS Online about a new study suggesting double mastectomies may be performed unnecessarily in many women.

Pictured: Mark Kris
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, May 21, 2014

A new study has found that driver mutations can be found in about two-thirds of lung adenocarcinomas, suggesting options for treatment with targeted therapies.

pictured: Martin S. Tallman
Profile
By Maureen Salamon, BA, Freelance Writer  |  Monday, May 19, 2014

Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

Pictured: William Tap
MSK at ASCO
By Media Staff  |  Thursday, May 15, 2014

New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

Pictured: Kenneth Offit
Q&A
By Andrea Peirce, BA, Writer/Editor  |  Monday, May 5, 2014

Memorial Sloan Kettering Clinical Genetics Service Chief Kenneth Offit discusses ways for women to clearly assess their risk for breast and ovarian cancers.

Pictured: Jedd Wolchok
In the News
By Jim Stallard, MA, Writer/Editor  |  Friday, May 2, 2014

Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American.

Pictured: Bhuvanesh Singh
Q&A
By Christina Pernambuco-Holsten, MA  |  Friday, April 25, 2014

The HPV vaccine has brought the link between HPV and cervical cancer to the attention of many Americans, but HPV is also behind the fastest-growing type of head and neck cancer in the nation.

In the News
By Jennifer Bassett, MA, Writer/Editor  |  Tuesday, April 22, 2014

Robin Roberts is joined on Good Morning America by Sergio Giralt, Chief of the Adult Bone Marrow Transplantation Service.

Cancer Guide
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, April 17, 2014

Molecular analysis of lung tumors can help guide treatment decisions. Memorial Sloan Kettering is one of only a handful of centers nationwide to offer this personalized approach to care.

Center News

Stay Informed

Get the latest information about cancer care and research every month.